TP53 and cancer: Recently, the Asian Cancer Research Group (ACRG) proposed a new molecular classification on the basis of Asian populations (mainly from Japan and Korea) [30, 31]: MSI, MSS/TP53+ (which means intact TP53), MSS/TP53−, and MSS/EMT (epithelial to mesenchymal transition).